Florida Cancer Specialists & Research Institute Announces Formation of Healthcare Analytics Company

Published On: March 28th, 2024Categories: Latest News

Fort Myers, Fla., March 27, 2024 – Florida Cancer Specialists & Research Institute, LLC (FCS) today announced the formation of a new healthcare analytics subsidiary. This new entity, named Vita Nova Insights, LLC d/b/a Vita Nova Insights,SM is wholly owned by Community Oncology Revitalization Enterprise, LLC (Core Ventures), FCS’ management services organization, and was created to serve as a precision oncology insights and real-world evidence platform.

Fort Myers, Fla., March 27, 2024  Florida Cancer Specialists & Research Institute, LLC (FCS) today announced the formation of a new healthcare analytics subsidiary. This new entity, named Vita Nova Insights, LLC d/b/a Vita Nova Insights,SM is wholly owned by Community Oncology Revitalization Enterprise, LLC (Core Ventures), FCS’ management services organization, and was created to serve as a precision oncology insights and real-world evidence platform.

Florida Cancer Specialists & Research Institute Announces Formation of Healthcare Analytics Company

Published On: March 28th, 2024Categories: Latest News

Fort Myers, Fla., March 27, 2024 – Florida Cancer Specialists & Research Institute, LLC (FCS) today announced the formation of a new healthcare analytics subsidiary. This new entity, named Vita Nova Insights, LLC d/b/a Vita Nova Insights,SM is wholly owned by Community Oncology Revitalization Enterprise, LLC (Core Ventures), FCS’ management services organization, and was created to serve as a precision oncology insights and real-world evidence platform.

Fort Myers, Fla., March 27, 2024  Florida Cancer Specialists & Research Institute, LLC (FCS) today announced the formation of a new healthcare analytics subsidiary. This new entity, named Vita Nova Insights, LLC d/b/a Vita Nova Insights,SM is wholly owned by Community Oncology Revitalization Enterprise, LLC (Core Ventures), FCS’ management services organization, and was created to serve as a precision oncology insights and real-world evidence platform.